Mainz Biomed B.V. (MYNZ) Revenue & Revenue Breakdown
Mainz Biomed B.V. Revenue Highlights
Latest Revenue (Y)
$895.48K
Latest Revenue (Q)
$214.76K
Mainz Biomed B.V. Revenue by Period
Mainz Biomed B.V. Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $895.48K | 69.00% |
| 2022-12-31 | $529.88K | -8.22% |
| 2021-12-31 | $577.35K | 16.98% |
| 2020-12-31 | $493.56K | 75.40% |
| 2019-12-31 | $281.39K | - |
Mainz Biomed B.V. generated $895.48K in revenue during NA 2023, up 69.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Mainz Biomed B.V. Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $214.76K | 18.22% |
| 2023-09-30 | $181.67K | -27.02% |
| 2023-06-30 | $248.94K | -0.46% |
| 2023-03-31 | $250.10K | 29.40% |
| 2022-12-31 | $193.28K | 99.69% |
| 2022-09-30 | $96.79K | -30.49% |
| 2022-06-30 | $139.24K | 38.46% |
| 2022-03-31 | $100.56K | -37.16% |
| 2021-12-31 | $160.04K | 10.88% |
| 2021-09-30 | $144.34K | -65.41% |
| 2021-06-30 | $417.31K | 189.12% |
| 2021-03-31 | $144.34K | 16.98% |
| 2020-12-31 | $123.39K | - |
| 2020-09-30 | $123.39K | - |
| 2020-06-30 | $123.39K | - |
| 2020-03-31 | $123.39K | 75.40% |
| 2019-12-31 | $70.35K | - |
| 2019-09-30 | $70.35K | - |
| 2019-06-30 | $70.35K | - |
| 2019-03-31 | $70.35K | - |
Mainz Biomed B.V. generated $214.76K in revenue during Q4 2023, up 18.22% compared to the previous quarter, and up 221.88% compared to the same period a year ago.
Mainz Biomed B.V. Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| GTH | Genetron | $650.71M | $201.32M |
| NOTV | Inotiv | $572.42M | $105.79M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| LAB | Standard BioTools | $106.34M | $37.20M |
| FONR | FONAR | $98.65M | $25.72M |
| STIM | Neuronetics | $71.35M | $16.45M |
| MDXH | MDxHealth SA | $70.19M | $19.83M |
| BDSX | Biodesix | $49.09M | $14.82M |
| PRE | Prenetics Global | $21.74M | $6.41M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| APDN | Applied DNA Sciences | $13.37M | $797.52K |
| MYNZ | Mainz Biomed B.V. | $895.48K | $214.76K |
| SERA | Sera Prognostics | $306.00K | - |
| NDRA | ENDRA Life Sciences | - | - |
MYNZ Revenue FAQ
What is Mainz Biomed B.V.’s yearly revenue?
Mainz Biomed B.V.'s yearly revenue for 2023 was $895.48K, representing an increase of 69.00% compared to 2022. The company's yearly revenue for 2022 was $529.88K, representing a decrease of -8.22% compared to 2021. MYNZ's yearly revenue for 2021 was $577.35K, representing an increase of 16.98% compared to 2020.
What is Mainz Biomed B.V.’s quarterly revenue?
Mainz Biomed B.V.'s quarterly revenue for Q4 2023 was $214.76K, a 18.22% increase from the previous quarter (Q3 2023), and a 11.11% increase year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $181.67K, a -27.02% decrease from the previous quarter (Q2 2023), and a 87.69% increase year-over-year (Q3 2022). MYNZ's quarterly revenue for Q2 2023 was $248.94K, a -0.46% decrease from the previous quarter (Q1 2023), and a 78.79% increase year-over-year (Q2 2022).
What is Mainz Biomed B.V.’s revenue growth rate?
Mainz Biomed B.V.'s revenue growth rate for the last 3 years (2021-2023) was 55.10%, and for the last 5 years (2019-2023) was 218.23%.